EUVIMEDEUVIMED entdecken
Open Access

N-Branched Tricyclic Guanidines as Novel Melanocortin-3 Receptor Agonists and Melanocortin-4 Receptor Antagonists

Nicholas A Weirath iD, Jonathan W P Zajac, Haley M Donow, Travis M Lavoi, Clemencia Pinilla, Radleigh G Santos, Ritu Prajapati, Robert Speth, Mark D Ericson iD, Sapna Sarupria iD, Marcello A Giulianotti, Carrie Haskell-Luevano iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.4c01556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Nicholas A Weirath und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry and the Institute for Translational Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455, United Sta…. Hauptthemen laut MEDLINE: Receptor, Melanocortin, Type 3, Receptor, Melanocortin, Type 4. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The melanocortin receptors are a class of centrally and peripherally expressed G protein-coupled receptors, of which the MC3R and MC4R subtypes are implicated in the regulation of appetite and energy homeostasis and can serve as potential therapeutic targets for disorders such as obesity and cachexia. An unbiased high-throughput mixture-based library screen was implemented to identify novel ligands with an emphasis on the identification of nanomolar-potent agonists of the mouse melanocortin-3 receptor. This screen yielded the discovery of an N-branched tricyclic guanidine scaffold (TPI2408) that contained three nanomolar potent mMC3R agonists and additional compounds that possessed antagonism for the mMC4R. The antagonist character of this scaffold library at the mMC4R was confirmed by a follow-up positional scanning antagonist screen. Additionally, molecular dynamics simulations herein provide mechanistic insight into the polypharmacological characteristics of melanocortin receptors. The disclosed materials have the potential to serve as important tools and SAR scaffolds in the study of melanocortin receptor function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Melanocortin, Type 3Receptor, Melanocortin, Type 4AnimalsMiceHumansStructure-Activity RelationshipGuanidinesMolecular Dynamics SimulationHEK293 Cells

Substanzen

Receptor, Melanocortin, Type 3Receptor, Melanocortin, Type 4Guanidines

Autor:innen und Institutionen

  • Department of Medicinal Chemistry and the Institute for Translational Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455, United States.
  • Department of Chemistry and Chemical Theory Center, University of Minnesota, Minneapolis, Minnesota 55455, United States.
  • Florida International University, Port St. Lucie, Florida 34978, United States.
  • Nova Southeastern University, 3301 College Avenue, Fort Lauderdale, Florida 33314, United States.
  • Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, 3300 S. University Dr., Fort Lauderdale, Florida 33328, United States.
  • Department of Pharmacology and Physiology, Georgetown University School of Medicine, 3900 Reservoir Rd. NW, Washington, District of Columbia 20007, United States.

ORCID-Profile: Nicholas A Weirath, Mark D Ericson, Sapna Sarupria, Carrie Haskell-Luevano

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Weirath, N. A., Zajac, J. W. P., Donow, H. M., Lavoi, T. M., Pinilla, C., Santos, R. G., Prajapati, R., Speth, R., Ericson, M. D., Sarupria, S., Giulianotti, M. A., & Haskell-Luevano, C. (2025). N-Branched Tricyclic Guanidines as Novel Melanocortin-3 Receptor Agonists and Melanocortin-4 Receptor Antagonists. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01556

Vancouver

Weirath NA, Zajac JWP, Donow HM, Lavoi TM, Pinilla C, Santos RG, et al. N-Branched Tricyclic Guanidines as Novel Melanocortin-3 Receptor Agonists and Melanocortin-4 Receptor Antagonists. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c01556

BibTeX
@article{Weirath2025,
  author = {Weirath, Nicholas A and Zajac, Jonathan W P and Donow, Haley M and Lavoi, Travis M and Pinilla, Clemencia and Santos, Radleigh G and Prajapati, Ritu and Speth, Robert and Ericson, Mark D and Sarupria, Sapna and Giulianotti, Marcello A and Haskell-Luevano, Carrie},
  title = {N-Branched Tricyclic Guanidines as Novel Melanocortin-3 Receptor Agonists and Melanocortin-4 Receptor Antagonists},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.4c01556}
}
Kostenlos starten →